Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans.
about
Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repairRemyelination therapy for multiple sclerosisElucidating the Role of Injury-Induced Electric Fields (EFs) in Regulating the Astrocytic Response to Injury in the Mammalian Central Nervous SystemA review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissueLeukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitorsArylsulfatase B modulates neurite outgrowth via astrocyte chondroitin-4-sulfate: dysregulation by ethanolChondroitin sulfate synthase-2 is necessary for chain extension of chondroitin sulfate but not critical for skeletal developmentChondroitin-4-sulfation negatively regulates axonal guidance and growthLocalized alteration of microtubule polymerization in response to guidance cues.Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury.Dynamic behaviors of astrocytes in chemically modified fibrin and collagen hydrogels.A chemical screen identifies novel compounds that overcome glial-mediated inhibition of neuronal regeneration.Chondroitin sulfate proteoglycans: structure-function relationship with implication in neural development and brain disordersGlobal analysis of neuronal phosphoproteome regulation by chondroitin sulfate proteoglycansLipoprotein lipase is a novel amyloid beta (Abeta)-binding protein that promotes glycosaminoglycan-dependent cellular uptake of Abeta in astrocytes.Smad proteins differentially regulate transforming growth factor-β-mediated induction of chondroitin sulfate proteoglycansChondroitin Sulfate Induces Depression of Synaptic Transmission and Modulation of Neuronal Plasticity in Rat Hippocampal Slices.Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury.An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.Delayed expression of cell cycle proteins contributes to astroglial scar formation and chronic inflammation after rat spinal cord contusionGenetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injuryRole of chondroitin sulfate proteoglycans in axonal conduction in Mammalian spinal cord.Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury.Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice.Role of extracellular factors in axon regeneration in the CNS: implications for therapy.Scar-mediated inhibition and CSPG receptors in the CNS.The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseasesManipulating the extracellular matrix and its role in brain and spinal cord plasticity and repair.Scar-modulating treatments for central nervous system injury.Molecular mechanisms of scar-sourced axon growth inhibitorsExtracellular matrices, artificial neural scaffolds and the promise of neural regeneration.Effect of dexamethasone on gliosis, ischemia, and dopamine extraction during microdialysis sampling in brain tissue.In vitro models of axon regeneration.Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.Axonal regrowth after spinal cord injury via chondroitinase and the tissue plasminogen activator (tPA)/plasmin system.Comparison of sensory neuron growth cone and filopodial responses to structurally diverse aggrecan variants, in vitro.Gene delivery to overcome astrocyte inhibition of axonal growth: an in vitro model of the glial scar.Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.Expression of hyaluronan and the hyaluronan-binding proteoglycans neurocan, aggrecan, and versican by neural stem cells and neural cells derived from embryonic stem cells.Inhibitors of myelination: ECM changes, CSPGs and PTPs.
P2860
Q21284516-21C29018-8518-458B-8A48-44F994CCE429Q26824246-2A51B051-C405-4B1B-9BDA-2B5B3BFA2E2CQ27344252-A03BD6C6-8EF9-4421-96C1-4749BCC4199AQ28394513-95A1D88D-2067-4468-9047-AFC58C7B4C17Q28511924-53C1D178-FE00-4B3E-A32F-030284DA5D27Q28571230-86617DB8-2A03-44E0-BAAA-EC20E51C5595Q28588352-CE049FA4-B6B3-4692-B35E-CA967BB9351CQ30483928-D80F9D1C-8FF9-474E-865B-009B9CAEB65EQ30496825-34D124F7-F26A-40CF-829F-7BDA35AA8E93Q30513561-31D926D3-32FF-43F8-AF66-3D5B69C1A81DQ30757657-36F66743-019C-4ECD-A80C-2E55937D12F5Q33548229-E933D8A0-B04A-434D-A66A-6FFF13ECAFA9Q33738641-A4854E20-65B3-4D82-80AD-716C1A053A82Q34634945-D95051E0-8A9B-450A-9D86-3226660EA09AQ34675772-FFE60CF2-7CEA-4B78-B208-6BA21EA15B0FQ35401997-ED78165F-E9B3-4924-B934-FF774EF23E63Q35649647-869E548D-9E13-4C4F-810E-C034ABD820A4Q35893779-6469B371-B5FF-4302-8F78-A35BB35B1AE5Q35999574-808F88FF-4A3C-4E2D-88A9-01277C4BF4C7Q36136722-08683254-E08E-416F-96DB-8194A92AD886Q36359579-B9622511-C308-4570-9DD4-304EB42CD2A6Q36493205-53ABC091-E3F5-469E-980D-3F4D8C62E993Q36807055-C53AE81B-DDE6-4D72-B318-A4AA63BB17BEQ37249700-0A2500E6-18DD-42E5-8653-5368C93DB23AQ37306814-260495F7-EB0F-41EE-857B-943A9D2057B6Q38029901-E020097B-CE5C-4F79-A2DD-21A0E4F4BC20Q38175970-4A23B194-6953-40F6-8BEF-BACA1661E266Q38179520-7DB5EA28-905B-452C-9815-CF439B2D1EE7Q38222632-A32C9A16-D78D-4FB4-B128-C0A8CFA7DEAEQ38246350-9F2F73D7-53E7-46A7-9356-0C039F34D644Q38264907-0742459A-B34B-4F41-905E-803F083C36DFQ38708576-4D05860C-12C6-4713-81F0-F12042709979Q38716618-52A1EBAD-9B0A-492C-B268-6397FD4B3EF7Q38777732-13863969-2E33-45A2-A7A3-8B1582AAE6E4Q38908215-EFCCE975-673C-42FB-AC01-195783B2C663Q39121874-20E942BA-EFEC-4F12-9CA8-153F193C5C1DQ39261846-470C5180-9E67-4EF4-B717-5E65536BCD15Q39266450-3AAB30DD-EF58-43F9-9382-2B741954B482Q40801833-5F6B2385-8C32-4E34-AE7C-DE273EEAD31AQ40804371-2C260ADC-2FA7-4958-800F-DDF48C6A21E5
P2860
Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inhibiting glycosaminoglycan c ...... droitin sulfate proteoglycans.
@en
type
label
Inhibiting glycosaminoglycan c ...... droitin sulfate proteoglycans.
@en
prefLabel
Inhibiting glycosaminoglycan c ...... droitin sulfate proteoglycans.
@en
P2093
P1476
Inhibiting glycosaminoglycan c ...... droitin sulfate proteoglycans.
@en
P2093
James W Fawcett
Thomas McCann
Tracy L Laabs
Yasuhiro Katagiri
P304
14494-14501
P356
10.1523/JNEUROSCI.2807-07.2007
P407
P577
2007-12-01T00:00:00Z